Pricing Log in Create free account

Septerna, Inc. (SEPN) vs Vera Therapeutics, Inc. (VERA)

Septerna, Inc. and Vera Therapeutics, Inc. are both Biotechnology companies. Septerna, Inc. and Vera Therapeutics, Inc. are of similar size ($2.2B and $2.2B). Vera Therapeutics, Inc. has the higher net margin (0.00% vs −24.5%) and the higher return on invested capital (0.00% vs −189.0%). Across the 14 metrics below, Septerna, Inc. leads on 8 and Vera Therapeutics, Inc. on 6.

Valuation

Metric SEPN VERA Biotechnology median
P/E n/m n/m 10.26
P/S 21.84 n/m 9.18
P/B 5.58 5.34 2.05
Price to free cash flow 18.36 n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 18.07 n/m 8.98
Earnings yield (1.13%) (19.32%) (34.89%)
Free cash flow yield 5.45% (15.55%) (24.52%)

Profitability

Metric SEPN VERA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (44.04%) 0.00% 0.00%
Net margin (24.51%) 0.00% 0.00%
Free cash flow margin 118.93% 0.00% 0.00%
Return on equity (6.34%) (91.75%) (50.12%)
Return on assets (4.94%) (72.32%) (45.60%)
Return on invested capital (189.01%) 0.00% 0.00%

Growth

Metric SEPN VERA Biotechnology median
Revenue growth (TTM) 13,520.11% — 6.26%
EPS growth (last fiscal year) 84.85% (69.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric SEPN VERA Biotechnology median
Debt to equity 0.00 0.18 0.00
Current ratio 4.99 10.92 4.89
Net debt to EBITDA 5.86 2.00 1.01

Dividend

Metric SEPN VERA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SEPN VERA Biotechnology median
Market cap 2.21b 2.17b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack